Michihito Onishi
Direktor/Vorstandsmitglied bei HISHOH Biopharma Co., Ltd.
Ursprung des Netzwerks ersten Grades von Michihito Onishi
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
HISHOH Biopharma Co., Ltd.
 HISHOH Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services HISHOH Biopharma Co., Ltd. is a Japanese company that develops allergen immunotherapy. The company was founded in 2021 by Toru Seo and Naoki Sakurai. Naoki Sakurai has been the CEO since 2021.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Michihito Onishi
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Cellusion Inc.
 Cellusion Inc. Miscellaneous Commercial ServicesCommercial Services Cellusion Inc. is a Japanese company that focuses on regenerating corneal endothelium using IPS cells to treat bullous keratopathy. The company is based in Tokyo, Japan. The company was founded in 2015 by Shigeto Shimmura, Kazuo Tsubota, Shin Hatou. | Miscellaneous Commercial Services | Director/Board Member | |
| Wake Forest University | College/University | Doctorate Degree |
Statistik
International
| Japan | 2 |
| Vereinigte Staaten | 2 |
Sektoral
| Commercial Services | 2 |
| Consumer Services | 2 |
Operativ
| Director/Board Member | 2 |
| Founder | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Toru Seo | 3 |
| Naoki Sakurai | 1 |
- Börse
- Insiders
- Michihito Onishi
- Unternehmensverbindungen
